Patients with kidney disease are at increased risk for a range of respiratory complications due to the complex interplay between renal dysfunction, fluid imbalance, and systemic inflammation. Respiratory complications in kidney disease commonly include pulmonary edema, pleural effusions, sleep-disordered breathing, and an increased susceptibility to infections such as pneumonia. Impaired renal function can lead to fluid retention, electrolyte disturbances, and acid-base imbalances, all of which can compromise lung mechanics and gas exchange. Effective management requires early recognition of symptoms such as shortness of breath, persistent cough, or hypoxia, alongside careful monitoring of fluid status and cardiovascular function. Interventions may include optimized dialysis protocols, respiratory support, pharmacological management, and targeted rehabilitation to maintain lung capacity and prevent complications. Respiratory complications in kidney disease also highlight the importance of multidisciplinary care, with nephrologists, pulmonologists, critical care specialists, and respiratory therapists collaborating to provide coordinated treatment plans. Preventive strategies, including vaccination, infection control measures, and patient education on symptom recognition, are crucial in reducing morbidity and improving outcomes. Emerging research explores the impact of novel therapies and personalized approaches to mitigate pulmonary risks in patients with chronic kidney disease. By understanding the mechanisms linking renal impairment and respiratory dysfunction, healthcare providers can implement timely interventions, improve quality of life, and reduce hospitalization rates, emphasizing the need for comprehensive, proactive management of respiratory health in this vulnerable patient population.
Title : Screening questionnaires for obstructive sleep apnea: An updated systematic review
Behzad Rahmati, Isfahan University of Medical Sciences, Iran (Islamic Republic of)
Title : Improving covid 19 candidate vaccine response through probiotics and micronutrient supplementation: Evaluating the role of TLR5
Zohre Eftekhari, Biotechnology Research Center, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Iatrogenic pneumothorax following nephrectomy: Case report
Chaimae Tahiri, National University Hospital Center of Fann, Senegal